Clinical Trials Logo

Lymph Node Cancer Metastatic clinical trials

View clinical trials related to Lymph Node Cancer Metastatic.

Filter by:
  • None
  • Page 1

NCT ID: NCT05873621 Recruiting - Rectal Cancer Clinical Trials

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy

(GreenEye-CRC)
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess the number of harvested locoregional lymph nodes in rectal cancer patients undergoing laparoscopic total mesorectal excision and indocyanine green (ICG)-guided lymphoadenectomy after neoadjuvant chemoradiation. The main questions it aims to answer are: - Does the use of ICG increase the total number of harvested lymph nodes? - Does the use of ICG increase the number of harvested extra-mesorectal lymph nodes? Participants will intraoperatively receive a trans-anal administration of ICG near to rectal cancer; during laparoscopic surgery, ICG-fluorescent nodes beyond the mesorectum will be separately excised and sent for pathology. A comparison will be performed with a recent cohort of patients affected by rectal cancer treated with standard surgery without the use of ICG.

NCT ID: NCT05040685 Completed - Clinical trials for Lymph Node Cancer Metastatic

Axillary Reverse Mapping in Breast Cancer

ARM
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The axillary mapping reverse (ARM) consists in differentiating the upper limb lymph nodes from the breast ones in order to preserve them and reduce the possibility of lymphedema. A significant decrease of lymphedema rates in patients who was possible associate ARM technique during the axillary surgery improving the quality of life of these patients. There are different visualisation techniques like fluorescence dye.

NCT ID: NCT02570399 Active, not recruiting - Clinical trials for Lymph Node Cancer Metastatic

High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients

Start date: February 26, 2015
Phase: N/A
Study type: Interventional

This is a prospective, multicentric, phase II and feasibility study aimed to address early and late side effects of hypofractionated ablative radiotherapy for oligometastatic patients with lymph node metastases for genito-urinary, gastro-intestinal and gynaecological cancer.